Live feed
·
INSIDERFilingvia Quantisnow
Gamida Cell Ltd. logo

Gamida Cell (GMDA) executive Patterson received 51,000 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Joshua F. Patterson (executive at Gamida Cell Ltd., GMDA) reported that they received 51,000 shares on Jan 28, 2022. After these transactions the filing shows 81,000 shares held directly.

Reporting person
Patterson Joshua F.
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 28, 2022Grant or award (A)Ordinary Shares+51,000--81,000 direct

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 28, 2022Grant or award (A)Employee Share Option (Right to Buy)On 77,900 Ordinary Shares1+77,900--77,900 direct

Holdings before and after

  • Ordinary Shares: 30,000 to 81,000 direct
  • Employee Share Option (Right to Buy): 0 to 77,900 direct

Footnotes from the filing

  1. 1. One fourth (1/4th) of the shares subject to the option award shall vest on January 28, 2023, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Patterson report in this GMDA Form 4?

Joshua F. Patterson (executive at Gamida Cell Ltd., GMDA) reported that they received 51,000 shares on Jan 28, 2022. After these transactions the filing shows 81,000 shares held directly.

How many GMDA shares does Patterson hold after this filing?

The filing shows 81,000 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for GMDA

Earlier insider filings at GMDA

Quantisnow market dataNASDAQ
Gamida Cell Ltd. logo
GMDA
Gamida Cell Ltd.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2018
Get push alerts for GMDA

Follow GMDA and get a push notification the moment its next story breaks.

Full GMDA profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GMDA (Gamida Cell Ltd.) and more on Quantisnow.